Fernando Rosas

Lecturer in Informatics and Complexity Science

Data updated

Papers

24 publications

Trials

0 clinical trials

Research Footprint

Fernando Rosas appears in 24 tracked papers (2021–2026), most studied alongside Psilocybin, LSD and DMT, across Depressive Disorders, Anxiety Disorders and Neuroimaging & Brain Measures.

Most-cited paper: Human brain effects of DMT assessed via EEG-fMRI (213 citations).

Frequent co-authors: Robin Carhart-Harris, David Nutt and David Erritzoe.

Background & Research

Fernando Rosas is a researcher at the University of Sussex and Imperial College London, specializing in complexity science and computational neuroscience. His work integrates machine learning to reveal how the human brain processes collective experiences and how environmental factors (setting) influence the quality of psychedelic states. His multidisciplinary background spans music composition, mathematics, and engineering.

Key Impact

Analyzes distributed complex systems in the brain to understand multi-agent dynamics and the 'mindset' in psychedelic experiences.

24

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

54 collaborators· click a node to visit their profile

Full network →

Compounds

PsilocybinLSDDMTPlaceboKetamine

Topics

Depressive DisordersAnxiety DisordersNeuroimaging & Brain MeasuresHealthy VolunteersMajor Depressive Disorder (MDD)Set & SettingEquity and EthicsSchizophreniaPersonality & Trait FactorsEating DisordersSuicidalityMedicinal Chemistry & Drug DevelopmentTreatment-Resistant Depression (TRD)PTSDObsessive-Compulsive Disorder (OCD)Palliative & End-of-Life DistressInterpersonal Functioning & Social ConnectednessMicrodosingCreativity

Top Collaborators

Affiliations

Institutions, companies, and organisations Fernando Rosas is associated with.

Imperial College London

academic

The Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).

View stakeholder →